scholarly article | Q13442814 |
P356 | DOI | 10.1021/AC0256991 |
P698 | PubMed publication ID | 12349978 |
P2093 | author name string | Thomas A Shaler | |
Dirk Chelius | |||
Pavel V Bondarenko | |||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | liquid chromatography-tandem mass spectrometry | Q117788892 |
liquid | Q11435 | ||
P304 | page(s) | 4741-4749 | |
P577 | publication date | 2002-09-01 | |
P1433 | published in | Analytical Chemistry | Q485223 |
P1476 | title | Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry | |
P478 | volume | 74 |
Q64102059 | A Review on Quantitative Multiplexed Proteomics |
Q34473671 | A label-free differential quantitative mass spectrometry method for the characterization and identification of protein changes during citrus fruit development. |
Q37013235 | A label-free mass spectrometry method for the quantification of protein isotypes. |
Q39859325 | A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation. |
Q33888463 | A posteriori quality control for the curation and reuse of public proteomics data |
Q33685804 | A proteomic study of microgravity cardiac effects: feature maps of label-free LC-MALDI data for differential expression analysis |
Q36828359 | A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration |
Q38102548 | A review on recent developments in mass spectrometry instrumentation and quantitative tools advancing bacterial proteomics |
Q30996936 | A software suite for the generation and comparison of peptide arrays from sets of data collected by liquid chromatography-mass spectrometry |
Q36168431 | Absolute quantification strategies in proteomics based on mass spectrometry. |
Q43097813 | Accurate protein complex retrieval by affinity enrichment mass spectrometry (AE-MS) rather than affinity purification mass spectrometry (AP-MS). |
Q31030306 | Advances in proteomics data analysis and display using an accurate mass and time tag approach. |
Q41773275 | Advantageous uses of mass spectrometry for the quantification of proteins |
Q37157865 | Analysis of organelles within the nervous system: impact on brain and organelle functions |
Q35027054 | Analyzing LC-MS/MS data by spectral count and ion abundance: two case studies |
Q35587480 | Application for proteomic techniques in studying osteoarthritis: a review |
Q38056688 | Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis |
Q37015350 | Biochemical individuality reflected in chromatographic, electrophoretic and mass-spectrometric profiles |
Q30950348 | Bioinformatics meets proteomics--bridging the gap between mass spectrometry data analysis and cell biology |
Q33338835 | Biomarker discovery in psychiatric disorders |
Q39032610 | Building proteomic tool boxes to monitor MHC class I and class II peptides |
Q39061545 | Cell line profiling to improve monoclonal antibody production. |
Q57976227 | Chapter 12 Phosphoproteomics |
Q46095722 | Chapter 8. Proteomic mapping of the vascular endothelium in vivo for vascular targeting |
Q37234005 | Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care. |
Q37636378 | Comparative and Quantitative Global Proteomics Approaches: An Overview |
Q37171039 | Comparative glycoproteomics: approaches and applications |
Q46568113 | Comparison of label-free methods for quantifying human proteins by shotgun proteomics. |
Q39494662 | Comparison of stable-isotope labeling with amino acids in cell culture and spectral counting for relative quantification of protein expression. |
Q35180200 | Comparison of the membrane proteome of virulent Mycobacterium tuberculosis and the attenuated Mycobacterium bovis BCG vaccine strain by label-free quantitative proteomics |
Q34145620 | Computational and statistical analysis of protein mass spectrometry data |
Q35009100 | Correlation of mRNA and protein in complex biological samples. |
Q27469058 | Decoding protein networks during virus entry by quantitative proteomics |
Q42729455 | Deglycosylation and label-free quantitative LC-MALDI MS applied to efficient serum biomarker discovery of lung cancer |
Q35098547 | Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma |
Q58068992 | Differential Label-free Quantitative Proteomic Analysis ofShewanella oneidensisCultured under Aerobic and Suboxic Conditions by Accurate Mass and Time Tag Approach |
Q38484213 | Differential label-free quantitative proteomic analysis of avian eggshell matrix and uterine fluid proteins associated with eggshell mechanical property |
Q37118484 | Differential protein expression by Porphyromonas gingivalis in response to secreted epithelial cell components |
Q33340658 | Direct tissue proteomics in human diseases: potential applications to melanoma research |
Q37623616 | Discovery of novel disease-specific and membrane-associated candidate markers in a mouse model of multiple sclerosis |
Q28551073 | Dynamic Proteomic Characteristics and Network Integration Revealing Key Proteins for Two Kernel Tissue Developments in Popcorn |
Q36926304 | Enrichment of distinct microfilament-associated and GTP-binding-proteins in membrane/microvilli fractions from lymphoid cells |
Q81698986 | Evaluation of confidence and reproducibility in quantitative proteomics performed by a capillary isoelectric focusing-based proteomic platform coupled with a spectral counting approach |
Q34033015 | Evaluation of normalization methods on GeLC-MS/MS label-free spectral counting data to correct for variation during proteomic workflows |
Q40861137 | Experimental Null Method to Guide the Development of Technical Procedures and to Control False-Positive Discovery in Quantitative Proteomics |
Q37943426 | From "clinical proteomics" to "clinical chemistry proteomics": considerations using quantitative mass-spectrometry as a model approach |
Q36429606 | Gel-based and gel-free quantitative proteomics approaches at a glance. |
Q42226771 | Generalized Linear and Mixed Models for Label-Free Shotgun Proteomics |
Q92631456 | Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics |
Q30606993 | ICan: an optimized ion-current-based quantification procedure with enhanced quantitative accuracy and sensitivity in biomarker discovery |
Q33502940 | IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation |
Q46668286 | Identification of Cultured and Natural Astragalus Root Based on Monosaccharide Mapping. |
Q42128121 | Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry |
Q37719739 | Identifying potential therapeutic targets of methicillin-resistant Staphylococcus aureus through in vivo proteomic analysis |
Q35477041 | Impact of data-dependent exclusion list based mass spectrometry on label-free proteomic quantification |
Q36022179 | Improving the TFold test for differential shotgun proteomics. |
Q37072898 | In silico instrumental response correction improves precision of label-free proteomics and accuracy of proteomics-based predictive models. |
Q51993191 | Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography-tandem mass spectrometry. |
Q51073279 | Integrative quantitation enables a comprehensive proteome comparison of two Mycoplasma pneumoniae genetic perturbations. |
Q36594542 | Keck Foundation Biotechnology Resource Laboratory, Yale University |
Q33726556 | Label-free mass spectrometry-based relative quantification of proteins separated by one-dimensional gel electrophoresis |
Q31049038 | Label-free quantification using MALDI mass spectrometry: considerations and perspectives |
Q45876632 | Label-free quantitative analysis for studying the interactions between nanoparticles and plasma proteins |
Q28573249 | Label-free quantitative analysis of one-dimensional PAGE LC/MS/MS proteome: application on angiotensin II-stimulated smooth muscle cells secretome |
Q37829699 | Less label, more free: approaches in label-free quantitative mass spectrometry. |
Q34983181 | Liquid Chromatography Mass Spectrometry-Based Proteomics: Biological and Technological Aspects |
Q47344805 | MS Western, a method of multiplexed absolute protein quantification is a practical alternative to Western blotting. |
Q39983550 | Making connections for life: an in vivo map of the yeast interactome |
Q37552845 | Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery |
Q34454989 | Mass spectrometry based glycoproteomics--from a proteomics perspective |
Q37487626 | Mass spectrometry-based approaches toward absolute quantitative proteomics. |
Q37416474 | Mass spectrometry-based label-free quantitative proteomics |
Q36974613 | Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases |
Q64814709 | Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases |
Q35118218 | Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma. |
Q33260636 | Merger of laser capture microdissection and mass spectrometry: a window into the amyloid plaque proteome |
Q24645983 | Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry |
Q37727186 | Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis |
Q93111203 | More than a Toxin: Protein Inventory of Clostridium tetani Toxoid Vaccines |
Q36881534 | Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures |
Q36991397 | Multiplex proteomics analysis of gender-associated proteins in Brugia malayi |
Q34551892 | Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues |
Q33562617 | PepC: proteomics software for identifying differentially expressed proteins based on spectral counting |
Q34600986 | Protein analysis by shotgun/bottom-up proteomics |
Q37802876 | Proteomic analysis of zymogen granules. |
Q35917830 | Proteomic informatics |
Q37442587 | Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease |
Q38748131 | Proteomics in the Assessment of the Therapeutic Response of Antineoplastic Drugs: Strategies and Practical Applications. |
Q91621205 | Proteomics of diphtheria toxoid vaccines reveals multiple proteins that are immunogenic and may contribute to protection of humans against Corynebacterium diphtheriae |
Q37868750 | Proteomics of extremophiles. |
Q21296824 | Proteomics of plant pathogenic fungi |
Q42587063 | Proteomics of the organohalide-respiring Epsilonproteobacterium Sulfurospirillum multivorans adapted to tetrachloroethene and other energy substrates |
Q36024256 | Proteomics strategies for protein identification |
Q79310635 | Quantitative analysis of complex peptide mixtures using FTMS and differential mass spectrometry |
Q38101159 | Quantitative analysis of global phosphorylation changes with high-resolution tandem mass spectrometry and stable isotopic labeling |
Q38024637 | Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present |
Q35599113 | Quantitative mass spectrometry of urinary biomarkers |
Q34713930 | Quantitative measurement of phosphoproteome response to osmotic stress in arabidopsis based on Library-Assisted eXtracted Ion Chromatogram (LAXIC) |
Q37721307 | Quantitative neuroproteomics: classical and novel tools for studying neural differentiation and function |
Q34339902 | Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with Paclitaxel resistance. |
Q28235630 | Quantitative proteomic analysis of post-translational modifications of human histones |
Q33749585 | Quantitative secretome and glycome of primary human adipocytes during insulin resistance |
Q37036058 | RIPPER: a framework for MS1 only metabolomics and proteomics label-free relative quantification |
Q47130775 | Ratiometric Mass Spectrometry for Cell Identification and Quantitation Using Intracellular "Dual-Biomarkers". |
Q27000073 | Recent advances in quantitative neuroproteomics |
Q90197115 | Refinements of LC-MS/MS Spectral Counting Statistics Improve Quantification of Low Abundance Proteins |
Q36729362 | Regulation of lipid metabolism by Dicer revealed through SILAC mice |
Q37197388 | Reversible acetylation regulates acetate and propionate metabolism in Mycobacterium smegmatis |
Q37607010 | SILAC surrogates: rescue of quantitative information for orphan analytes in spike-in SILAC experiments |
Q36713554 | Segmentation of precursor mass range using "tiling" approach increases peptide identifications for MS1-based label-free quantification |
Q36370962 | Serum Carbonic Anhydrase 1 is a Biomarker for Diagnosis of Human Schistosoma mansoni Infection |
Q38089202 | Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution |
Q37398849 | Stable isotope labeling and label-free proteomics of Drosophila parkin null mutants |
Q33926837 | Stable isotope-free relative and absolute quantitation of protein phosphorylation stoichiometry by MS |
Q37569894 | Stable, reproducible, and automated capillary zone electrophoresis-tandem mass spectrometry system with an electrokinetically pumped sheath-flow nanospray interface |
Q30779337 | Systematic assessment of survey scan and MS2-based abundance strategies for label-free quantitative proteomics using high-resolution MS data. |
Q31036432 | Systematic evaluation of data-independent acquisition for sensitive and reproducible proteomics-a prototype design for a single injection assay. |
Q34109658 | Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanisms |
Q33700805 | Target profiling of a small library of phosphodiesterase 5 (PDE5) inhibitors using chemical proteomics. |
Q37318182 | Targeting and imaging signature caveolar molecules in lungs |
Q38030883 | The application of quantification techniques in proteomics for biomedical research |
Q33745481 | The host targeting motif in exported Plasmodium proteins is cleaved in the parasite endoplasmic reticulum. |
Q84561065 | The pros and cons of peptide-centric proteomics |
Q37720601 | The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science |
Q37056209 | The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders |
Q36279053 | Tissue proteomics using capillary isoelectric focusing-based multidimensional separations |
Q37976002 | To label or not to label: applications of quantitative proteomics in neuroscience research |
Q38022563 | Tools and challenges for diversity-driven proteomics in Brazil. |
Q38537236 | Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques |
Q37866309 | Understanding and optimizing electrospray ionization techniques for proteomic analysis |
Q38256387 | Utilising proteomic approaches to understand oncogenic human herpesviruses (Review). |
Q30382070 | multiplierz: an extensible API based desktop environment for proteomics data analysis. |
Search more.